Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CriSP-HS: Cold Stored Platelets in Hemorrhagic Shock
NCT04667468Phase 2Completed
- Start
- Jun 2022
- Primary completion
- Oct 2023
- Modality
- Tissue Cells
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cold-stored platelet concentrate in hemorrhagic shock (2 arms). Primary endpoint: Study Feasibility at 30 days. Started Jun 2022; status: completed.
02
Drugs
cold-stored platelet concentrate
03
Conditions
hemorrhagic shock
Beyond the preview
Go deeper on NCT04667468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04667468.